BOSTON SCIENTIFIC CORP
BOSTON SCIENTIFIC CORP
MARLBOROUGH, MA
Loading...
Price History
Market Data
| Market Cap | 83.39B |
| P/E Ratio | 28.97 |
| P/B Ratio | 3.44 |
| EPS | 1.94 |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 1.62 |
| Currency | USD |
Key Financial Metrics
20.07B
Revenue
2.89B
Net Income
1.94
EPS (Diluted)
5.50B
Free Cash Flow
Profitability
Gross Margin
69.0%
Operating Margin
18.0%
Net Profit Margin
14.4%
EBITDA
5.97B
Returns & Efficiency
Return on Assets (ROA)
6.6%
Return on Equity (ROE)
11.9%
Dividend Yield
-
EPS
1.94
Financial Health
Total Assets
43.67B
Total Debt
11.44B
Debt to Equity
-
Current Ratio
1.62
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Measuring, Analyzing & Controlling Instruments |
| HQ | MARLBOROUGH, MA |
| Fiscal Year | 2025 |
Peers
STRYKER CORP
SYK
113.24B
P/E: --
3M CO
MMM
86.42B
P/E: --
41.26B
P/E: --
RESMED INC
RSMDF
37.64B
P/E: --
DEXCOM INC
DXCM
22.94B
P/E: --
21.69B
P/E: 35.1
PENUMBRA INC
PEN
12.76B
P/E: 85.5
GLOBUS MEDICAL INC
GMED
12.23B
P/E: 29.9
Quick Links
Financial Statistics
Valuation
Market Cap$83.39B
P/E Ratio (TTM)29.0
Price to Book3.44
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin69.0%
Operating Margin18.0%
Net Margin14.4%
ROE11.9%
ROA6.6%
Leverage & Liquidity
Debt to Equity-
Current Ratio1.62
Total Debt$11.44B
Total Assets$43.67B
Stockholders' Equity$24.23B
Income Statement (FY 2025)
Revenue$20.07B
Gross Profit$13.86B
Operating Income$3.61B
Net Income$2.89B
EPS (Diluted)$1.94
Cash Flow (FY 2025)
Free Cash Flow$5.50B
Cash & Equivalents$1.97B
Revenue Growth0.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 300 BOSTON SCIENTIFIC WAY MARLBOROUGH, MA 01752-1234 |
| Phone | 508-683-4000 |
| Incorporated | DE, US |
| EIN | 042695240 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 1.48B |
| Stockholders' Equity | $24.23B |
| Cash & Equivalents | $1.97B |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-22
Local
425
Prospectus Communications
Prospectus communications under Securities Act
Filed: 2026-04-22
Local
S-4/A
Amended M&A Registration
Amendment to merger registration
Filed: 2026-03-30
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-30
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-03-18
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-03-18
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-03-18
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | BOSTON SCIENTIFIC CORP |
| Ticker | BSX |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Measuring, Analyzing & Controlling Instruments |
| Headquarters | MARLBOROUGH, MA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 83.39B |
| Revenue | 20.07B |
| Net Income | 2.89B |
| P/E Ratio | 28.97 |
| EPS | 1.94 |
| Net Margin | 14.4% |
| ROE | 11.9% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...